(-)-Noroxymorphone
33522-95-1O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3)[C@H]1O5HLMSIZPQBSYUNL-IPOQPSJVSA-NNoroxymorphone is a member of phenanthrenes.
33522-95-1DEA NFLIS-Drug Category -> Narcotic Analgesics
DEA Schedule II Controlled Substance
Pharmaceuticals -> Metabolite of Naloxone, Oxycodone
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 52% (79 of 152) of all reports.
Danger
H301 (27%): Toxic if swallowed [Danger Acute toxicity, oral]
P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P316, P301+P317, P302+P352, P304+P340, P317, P321, P330, P333+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 152 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
DEA schedule II controlled substance
REACH registered substance: (5α)-4,5-epoxy-3,14-dihydroxymorphinan-6-one (EC: 251-561-5)
BeschreibungNoroxymorphone (Item No. 15903) is an analytical reference standard that is structurally categorized as an opioid. It is an active metabolite of oxycodone , noroxycodone (Item Nos. 15902 | 20407), and oxymorphone that can be detected in plasma and urine. Noroxymorphone is also an immediate precursor in the synthesis of several opioids, including naltrexone (Item Nos. 15520 | ISO60192) and naloxone (Item Nos. 15594 | ISO60191). Noroxymorphone is regulated as a Schedule II compound in the United States. This product is intended for research and forensic applications.
VerwendenA metabolite of Naloxone and Naltrexone
DTXSID80955145CHEBI:187724